The hair cycle and hair follicle structure are highly affected by various hormones. Androgens—
such as testosterone (T); dihydrotestosterone (DHT); and their prohormones …

Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in
women. The onset may be at any age following puberty and the frequency increases with …

Androgenetic alopecia (AGA) is the most diagnosed hair loss dysfunction. Its
physiopathology comprises a genetic predisposition affording an exacerbated response of …

Objective To determine the current state of knowledge and provide evidence-based
recommendations that could be valid for all specialists taking care of female pattern hair loss …

Female androgenetic alopecia or female-pattern hair loss (FPHL) is highly prevalent and
has a great impact on the quality of life. The treatment is a routine challenge in …

Pattern hair loss is the most common form of hair loss in both women and men. Male pattern
hair loss, also termed male androgenetic alopecia (M‐AGA), is an androgen‐dependent trait …

Androgenetic alopecia (AGA) affects physical and mental health with limited therapeutic
options. Novel materials and delivery methods have considerable potential to improve the …

Androgens, genetic susceptibility, chronic inflammation, oxidative stress, internal and
external environmental triggers such as ultraviolet light, pollutants, aging, poor nutrition, as …

Tofacitinib is a Janus kinase 3 (JAK3) inhibitor that promotes hair growth; however, the
efficacy and mechanism of this effect are not yet understood. This study aimed to evaluate …

Androgenetic alopecia is the most common cause of hair loss aggravated by increased life
pressure, tension, and anxiety. Although androgenetic alopecia (AGA) does not significantly …